International Journal of Molecular Medical Science, 2024, Vol.14, No.5, 264-273 http://medscipublisher.com/index.php/ijmms 9 we can fully realize the promise of genetic marker-based screening and prevention strategies, paving the way for a new era in cervical cancer control. Acknowledgments We thank the anonymous reviewers for their insightful comments and suggestions for the manuscript. Funding This work was not supported by any individual or organization. Conflict of Interest Disclosure The authors affirm that this research was conducted without any commercial or financial relationships that could be construed as a potential conflict of interest. References AieshaKhatun N., and Gudi S.N., 2021, A comparative study of visual inspection with acetic acid and papsmear in screening cervical intraepithelial neoplasia, Sch Int J ObstetGynec, 4(6): 241-249. Arbyn M., Ronco G., Anttila A., Meijer C., Poljak M., Ogilvie G., Koliopoulos G., Nauclér P., Sankaranarayanan R., and Peto J., 2012, Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer, Vaccine, 30(5): F88-F99. https://doi.org/10.1016/j.vaccine.2012.06.095 Bruni, L., Serrano, B., Roura, E., Alemany, L., Cowan, M., Herrero, R., Poljak P., Murillo R., Broutet N., Riley L., and de Sanjose S., 2022, Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis, The Lancet Global Health, 10(8): e1115-e1127. https://doi.org/10.1016/S2214-109X(22)00241-8 Chen S.Y., 2024, Optimizing drug therapy using genomic information: a pathway to personalized medicine, International Journal of Molecular Medical Science, 14(1): 61-68. http://dx.doi.org/10.5376/ijmms.2024.14.0009 Cohen A.C., Roane B.M., and Leath III C.A., 2020, Novel therapeutics for recurrent cervical cancer: moving towards personalized therapy, Drugs, 80(3): 217-227. https://doi.org/10.1007/s40265-019-01249-z Comparetto C., and Borruto F., 2021, Genetic screening of cervical cancer, OBM Genetics, 5(3): 1-37. https://doi.org/10.21926/obm.genet.2103132 Espinosa A., Alfaro A., Román-Basaure E., Guardado-Estrada M., Palma Í., Serralde C., Medina I., Juárez E., Bermúdez M., Marquez E., Borges-Ibáñez M., Muñoz-Cortez S., Alcántara-Vázquez A., Alonso P., Curiel-Valdez J., Kofman S., Villegas N., and Berumen J., 2013, Mitosis is a source of potential markers for screening and survival and therapeutic targets in cervical cancer, PLoS ONE, 8(2): e55975. https://doi.org/10.1371/journal.pone.0055975 Gaisa M.M., Sigel K.M., Deshmukh A.A., Lenskaya V., Chan C.A., Silvera R., Winters J., and Liu Y., 2021, Comparing anal cancer screening algorithms using cytology and human papillomavirus DNA testing in 3 high-risk populations, The Journal of infectious diseases, 224(5): 881-888. https://doi.org/10.1093/infdis/jiaa801 Gradissimo A., and Burk R., 2017, Molecular tests potentially improving HPV screening and genotyping for cervical cancer prevention, Expert Review of Molecular Diagnostics, 17: 379-391. https://doi.org/10.1080/14737159.2017.1293525 Hou X., Shen G., Zhou L., Li Y., Wang T., and Ma X., 2022, Artificial intelligence in cervical cancer screening and diagnosis, Frontiers in Oncology, 12: 851367. https://doi.org/10.3389/fonc.2022.851367 Jeannot E., Latouche A., Bonneau C., Calméjane M., Beaufort C., Ruigrok-Ritstier K., Bataillon G., Chérif L., Dupain C., Lecerf C., Popovic M., Rochefordière A., Lécuru F., Fourchotte V., Jordanova E., Leyen H., Tran-Perennou C., Legrier M., Dureau S., Raizonville L., Roufai D., Tourneau C., Bièche I., Rouzier R., Berns E., Kamal M., and Scholl S., 2021, Circulating HPV DNA as a marker for early detection of relapse in patients with cervical cancer, Clinical Cancer Research, 27(21): 5869-5877. https://doi.org/10.1158/1078-0432.CCR-21-0625 Keating J., Ince T., and Crum C., 2001, Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis, Advances in Anatomic Pathology, 8: 83-92. https://doi.org/10.1097/00125480-200103000-00004 Lee S., Chae D., Lee S., Lim Y., An J., Chae C., Kim B., Bhak J., Bolser D., and Cho D., 2020, Efficient mutation screening for cervical cancers from circulating tumor DNA in blood, BMC Cancer, 20: 1-10. https://doi.org/10.1186/s12885-020-07161-0 Leeuwen R., Oštrbenk A., Poljak M., Zee A., Schuuring E., and Wisman G., 2018, DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort, International Journal of Cancer, 144: 746-754. https://doi.org/10.1002/ijc.31897
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==